Gilead Sciences, Inc. (GILD)

S&P 500: 764.16
Change: 1.56%

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

Avatar kile4784 (< 20) Submitted: 3/17/08 4:20 PM : Start Price: $48.17 GILD Score: 29.24

This company expects a 26-29 percent in product sales this fiscal year due to its new products.

Featured Broker Partners